- Home
- DGHI vs XAIR Comparison
DGHI vs XAIR Comparison
Compare DGHI & XAIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DGHI
- XAIR
- Stock Information
- Founded
- DGHI 2017
- XAIR 2011
- Country
- DGHI United States
- XAIR United States
- Employees
- DGHI N/A
- XAIR N/A
- Industry
- DGHI Finance: Consumer Services
- XAIR Medical/Dental Instruments
- Sector
- DGHI Finance
- XAIR Health Care
- Exchange
- DGHI Nasdaq
- XAIR Nasdaq
- Market Cap
- DGHI 32.6M
- XAIR 34.7M
- IPO Year
- DGHI N/A
- XAIR N/A
- Fundamental
- Price
- DGHI $1.92
- XAIR $0.53
- Analyst Decision
- DGHI Strong Buy
- XAIR Strong Buy
- Analyst Count
- DGHI 1
- XAIR 4
- Target Price
- DGHI $2.50
- XAIR $3.67
- AVG Volume (30 Days)
- DGHI 271.0K
- XAIR 633.8K
- Earning Date
- DGHI 11-15-2024
- XAIR 11-11-2024
- Dividend Yield
- DGHI N/A
- XAIR N/A
- EPS Growth
- DGHI N/A
- XAIR N/A
- EPS
- DGHI N/A
- XAIR N/A
- Revenue
- DGHI $38,327,380.00
- XAIR $2,342,000.00
- Revenue This Year
- DGHI N/A
- XAIR $640.47
- Revenue Next Year
- DGHI N/A
- XAIR $286.81
- P/E Ratio
- DGHI N/A
- XAIR N/A
- Revenue Growth
- DGHI 97.65
- XAIR 685.91
- 52 Week Low
- DGHI $0.84
- XAIR $0.30
- 52 Week High
- DGHI $2.54
- XAIR $2.36
- Technical
- Relative Strength Index (RSI)
- DGHI 61.73
- XAIR 55.11
- Support Level
- DGHI $1.60
- XAIR $0.42
- Resistance Level
- DGHI $2.20
- XAIR $0.54
- Average True Range (ATR)
- DGHI 0.25
- XAIR 0.06
- MACD
- DGHI 0.04
- XAIR 0.00
- Stochastic Oscillator
- DGHI 65.96
- XAIR 48.85
About DGHI Digihost Technology Inc. Common Subordinate Voting Shares
Digihost Technology Inc is a blockchain company focused on Bitcoin mining. The company's mining facility is located in Buffalo, New York, and is equipped with an 18.7 MVA 115,000-kilovolt ampere outdoor substation with an option to increase the power output to 42MVA.
About XAIR Beyond Air Inc.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.